Apply for funding

Get the $VITA token

Become a member

$3.5m+
Research Funded
$4.5m+
Liquid Funds
9000+
Community Members

Apply for funding

Submit a project

Get the $VITA token

Get $VITA

Become a member

Become a member
$3.5m+
Research Funded
$4.5m+
Liquid Funds
9000+
Community Members
15 Projects funded with $3.5 million
See all projects

IPNFTs & equity deals

Contribute to treasury

ApoptoSENS - Senolytic CAR-NK Cells

IP-NFT

Senescent cells accumulate with age and are associated with numerous diseases. Dr. Amit Sharma’s team have identified senescence-specific cell surface biomarkers which will act as targets for developing Chimeric Antigen Receptor Natural Killer (CAR-NK) cells aiming to precisely and safely eliminate senescent cells in vivo.

$ 253,000
raised
View Project

Scheibye-Knudsen Lab

IP-NFT

What if therapeutics to slow down the aging process and prevent age-related disease already existed? The Scheibye-Knudsen Lab will use advanced machine learning to crunch the data from 1.04 billion prescriptions to understand the impact of drugs on human lifespan.

$ 250,000
raised
View Project

Discovery of novel mitophagy activators for Alzheimer’s disease

IP-NFT

Mitophagy - the mechanism to recycle mitochondria - becomes dysregulated with age and is thought to be a driver of Alzheimer’s and other age-related diseases. The Fang lab aims to use a combination of artificial intelligence and a wet-lab validation platform to identify new mitophagy-activating drug candidates.

$ 300,000
raised
View Project

Turn Biotechnologies

Equity

Turn Bio develops mRNA medicines that induce the body to heal itself by instructing specific cells to fight disease or repair damaged tissue. They are reprogramming the epigenome – a network of chemical compounds and proteins controlling cell functions to restore capabilities that are lost with age.

$ 1,000,000
raised
View Project

Non-profit initiatives

Make a donation

Support of Clinical Trial - The Effect of Regular Exercise & Intermittent Rapamycin Dosing

Grant

This clinical trial aims to investigate whether periods of time where the mechanistic target of Rapamycin (mTOR) pathway is activated via exercise, combined with alternate periods of time where mTOR is inhibited using Sirolimus (Rapamycin), will result in greater muscle performance in older adults compared with just exercise alone.

$ 50,000
raised
View Project

Discover more longevity science projects funded by VitaDAO

See all projects
RECENT BLOG POSTS
VitaDAO Letter: ’Tis the Season (Of Governance)
VitaDAO Letter: ’Tis the Season (Of Governance)
Awareness
March 28, 2023
The Mouse Longevity Chronicles: Unraveling Aging with Dr. Richard Miller during The Aging Science podcast by VitaDAO
The Mouse Longevity Chronicles: Unraveling Aging with Dr. Richard Miller during The Aging Science podcast by VitaDAO
Awareness
Longevity
March 23, 2023
‍February Longevity Research Newsletter‍
‍February Longevity Research Newsletter‍
Awareness
Longevity
March 10, 2023
Exploring the Frontiers of Science: Breakthroughs, Funding Challenges, and Replication Crisis with Alaattin Kaya during The Aging Science podcast by VitaDAO
Exploring the Frontiers of Science: Breakthroughs, Funding Challenges, and Replication Crisis with Alaattin Kaya during The Aging Science podcast by VitaDAO
Awareness
Longevity
March 9, 2023
Our Partners

Are you working on the next longevity science breakthrough?

The VitaDAO Genesis hoodie is now available

Order now